360° Coverage : Roche's Competitive Advantage

2 Updates

Roche's Competitive Advantage

Apr 11 2014, 8:18am CDT | by

Roche Holdings has managed to grow its revenues and earnings at an impressive rate, whereas other big pharmaceutical firms have suffered due to several major drugs losing patent protection. Roche...

Filed under: news

 
 
 

20 weeks ago

Roche's Competitive Advantage

Apr 11 2014, 8:18am CDT | by

Roche Holdings has managed to grow its revenues and earnings at an impressive rate, whereas other big pharmaceutical firms have suffered due to several major drugs losing patent protection. Roche has distinguished itself due to its focus on biotechnology research and development (R&D) and leadership in oncology (cancer therapeutics). Given that the R&D productivity has declined over the years as far as small molecules are concerned, and the fact that there is a visible shift towards targeted therapies, Roche stands to gain. In this analysis we’ll look at Roche’s competitive advantage and how it fits in the shifting pharmaceutical landscape.

Our price estimate for Roche stands at $36.80, which is roughly inline with the market price.

See our complete analysis for Roche

Dominance In The Growing Cancer Market
/>

Roche has one of the strongest and most profitable drug portfolios in cancer therapeutics market. Three of its major drugs Rituxan/MabThera, Avastin and Herceptin are used for treating a variety of cancer forms including blood cancer, breast cancer and colorectal cancer. The combined sales from these drugs stood at over CHF 19.28 billion in 2013, or roughly $21.8 billion at the current exchange rate. This accounted for around 53% of Roche’s total pharmaceutical revenues during the year. Additionally, its total oncology (cancer therapeutics) sales constituted roughly 62% of its pharmaceuticals business which clearly showcases Roche’s success in this area. Despite the fact that individual sales of Rituxan/MabThera, Avastin and Herceptin stood between $6.8 and $7.8 billion, their growth was still healthy. Avastin saw its revenues jump by 13% in 2013 due to its demand for the treatment of ovarian cancer in Europe and increased use for colorectal cancer in both, Europe and the U.S.

The opportunity in oncology comes from the fact that global incidence of cancer is expected to increase from about 12.7 million in 2008 to 21.3 million in 2030. In addition, the number of deaths is likely to show a similar growth trajectory as depicted in the chart below. Treating Cancer can be tricky as it is a not a single disease, and has more than 200 types and thousands of subtypes affecting more than 60 organs. This means that the medicines have to be very specific and targeted. Being the biggest biotech firm in the world with a strong technical know-how, Roche has developed several biologics to treat cancer. Unlike small molecule drugs, biologics tend to be more targeted and attach themselves to specific cell receptors associated with the disease process.

Biologics Are The Way To Go As Small Molecule Drug R&D Productivity Declines
/>

Roche has maintained strong focus on biotech research and development (R&D), especially since its acquisition of Genentech. In both absolute terms and as a percentage of revenues, it spends more amount on R&D activities as compared to its competitors such as Pfizer, Merck and Johnson & Johnson. The company currently has 14 biopharmaceutical drugs in the market and another 39 investigational biopharmaceuticals in its drug pipeline. Additionally, seven of its 10 highest selling drugs are biopharmaceuticals. Given that R&D productivity has declined for small molecule drugs over the last few years, biologics may be the way to go. The shift is clear as 71% of the revenue generated by top 10 drugs in 2012 came from biotech products.

See More at Trefis | View Interactive Institutional Research (Powered by Trefis)
/>

Like our charts? Embed them in your own posts using the Trefis WordPress Plugin.

 
Update
2

1 day ago

Khazanah throws MAS RM6b lifeline

Aug 29 2014 5:01pm CDT | Source: Business Times Singapore

August 30, 2014 1:15 AMKHAZANAH Nasional will inject RM6 billion (SS$2.4 billion) over three years to resuscitate loss-making Malaysia Airlines (MAS) under a recovery plan that includes even an Act of Parliament. Other key moves are migrating its operations, assets and liabilities to a new company (NewCo) and slashing the workforc ...
Source: Business Times Singapore   Full article at: Business Times Singapore
 

 
Update
1

2 days ago

MAS posts loss of RM307m for Q2

Aug 28 2014 5:00pm CDT | Source: Business Times Singapore

August 29, 2014 1:13 AMMALAYSIA Airlines (MAS) registered a loss of RM307 million (S$122 million) for the second quarter to end-June, but warned of worse to come in the second half when the "full financial impact of t ...
Source: Business Times Singapore   Full article at: Business Times Singapore
 

 

Don't miss ...

 

<a href="/latest_stories/all/all/30" rel="author">Forbes</a>
Forbes is among the most trusted resources for the world's business and investment leaders, providing them the uncompromising commentary, concise analysis, relevant tools and real-time reporting they need to succeed at work, profit from investing and have fun with the rewards of winning.

 

blog comments powered by Disqus

Latest stories

For DINK couples, outsourcing parenthood is cool
New York, Aug 31 (IANS) For double-income-no-kid (DINK) couples, raising a child is the most difficult part. For them, creches and day-care centres in the marketplace are no less than playing the role of real parents.
 
 
Ancient metal workers were not treated as slaves
London, Aug 31 (IANS) Ancient metal workers were highly regarded for their skills and were not treated as slaves as popular narratives suggest, says a study.
 
 
Five new monkey species discovered
London, Aug 31 (IANS) Conservationists have discovered five new monkey species in South America that have, since, been added to the animal record books.
 
 
Soon batteries to run on sugar
New York, Aug 31 (IANS) In a breakthrough to develop long-lasting batteries for smartphones and other gadgets, scientists have successfully created a sugar biobattery that completely converts the chemical energy in sugar substrates into electricity.
 
 
 

Latest from the Network

Aaron Paul enjoying 'lighter' role
Aaron Paul is enjoying starring in a ''lighter'' show after 'Breaking Bad'. The 34-year-old star played meth manufacturer Jesse Pinkman in the US drama series for five years and while he is pleased to be lending his...
Read more on Celebrity Balla
 
Self-critical Ariana Grande
Ariana Grande says she's too critical of her appearance. The 21-year-old beauty insists that although she's an international pop star, she still feels the same pressure to look good as other young women and is trying...
Read more on Celebrity Balla
 
Lily Allen's husband doesn't mind marriage songs
Lily Allen says her husband is comfortable with her discussing intimate details of their personal life. The London-born singer is preparing to hit the road with material from her new album 'Sheezus' and Lily insists her...
Read more on Celebrity Balla
 
Abe glad Modi visited Kyoto
Kyoto, Aug 31 (IANS) Japan Prime Minister Shinzo Abe Sunday said he was happy his Indian counterpart Narendra Modi toured the country's ancient capital Kyoto. "I am very glad that Modi enjoyed the cultural heritage of...
Read more on Politics Balla
 
Modi leaves for Tokyo
Kyoto, Aug 31 (IANS) Indian Prime Minister Narendra Modi departed for Tokyo Sunday evening, on the second day of his five-day visit to Japan. "Goodbye Kyoto," the external affairs ministry spokesman tweeted, as Modi...
Read more on Politics Balla
 
For DINK couples, outsourcing parenthood is cool
New York, Aug 31 (IANS) For double-income-no-kid (DINK) couples, raising a child is the most difficult part. For them, creches and day-care centres in the marketplace are no less than playing the role of real parents...
Read more on Celebrity Balla
 
Philippines seeking defence ties with India after China's moves
Manila, Aug 31 (IANS) Worried over increasingly aggressive moves of China to stake claim on disputed reefs in the South China Sea, the Philippines is looking at establishing defence cooperation with allies, including...
Read more on Politics Balla
 
Ancient metal workers were not treated as slaves
London, Aug 31 (IANS) Ancient metal workers were highly regarded for their skills and were not treated as slaves as popular narratives suggest, says a study. In the course of ongoing excavations at Timna Valley in...
Read more on Apple Balla
 
World Cup is all that matters, not rankings: Clarke
Melbourne, Aug 31 (IANS) Australia cricket captain Michael Clarke feels all that matters is winning the World Cup and not the rankings. Australia are currently the No.1 ranked ODI team followed by India and South...
Read more on Sport Balla
 
Kim's daughter to follow her beauty ritual soon?
Los Angeles, Aug 31 (IANS) It seems like reality TV star Kim Kardashian's 14-month-old daughter North will take after her mother when it comes to maintaining a strict beauty routine as the little one already likes...
Read more on Celebrity Balla